Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Or

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Efficacies of ABT-773, a new ketolide, against experimental bacterial infectionsM J Mitten, J Meulbroek, M Nukkala, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analoguesR L Elliott, D Pireh, G Griesgraber, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Current Pharmaceutical Design|April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Efficacies of ABT-773, a new ketolide, against experimental bacterial infectionsM J Mitten, J Meulbroek, M Nukkala, et al.
Journal of Medicinal Chemistry|May 30, 1998
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analoguesR L Elliott, D Pireh, G Griesgraber, et al.
The Journal of Investigative Dermatology|May 8, 1999
A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Journal of Medicinal Chemistry|November 16, 2001
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogensZ Ma, R F Clark, A Brazzale, et al.
Current Pharmaceutical Design|April 10, 1999
Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseasesK W Mollison, T A Fey, D M Gauvin, et al.
Pageof 3